Other TGF-β inhibitors, such as the small molecule inhibitor Vactosertib or monoclonal antibodies targeting TGF-β, are under investigation in various cancers, representing alternative approaches to target this pathway (88). The gene discussed is TGFB1; the disease is cancer.